Sensitisation to Amaranthus retroflexus pollen is very common in tropical and subtropical countries. In this study we aimed to produce a recombinant allergenic Ole e 1-like protein from the pollen of this weed. To predict cross-reactivity of this allergen (Ama r 1) with other members of the Ole e 1-like protein family, the nucleotide sequence homology of the Ama r 1 was investigated. The expression of Ama r 1 in Escherichia coli was performed by using a pET-21b(+) vector. The IgE-binding potential of recombinant Ama r 1 (rAma r 1) was evaluated by immunodetection and inhibition assays using 26 patients' sera sensitised to A. retroflexus pollen. The coding sequence of the Ama r 1 cDNA indicated an open reading frame of 507 bp encoding for 168 amino acid residues which belonged to the Ole e 1-like protein family. Of the 26 serum samples, 10 (38.46%) had significant specific IgE levels for rAma r 1. Immunodetection and inhibition assays revealed that the purified rAma r 1 might be the same as that in the crude extract. Ama r 1, the second allergen from the A. retroflexus pollen, was identified as a member of the family of Ole e 1-like protein.
Keyphrases
- escherichia coli
- amino acid
- poor prognosis
- end stage renal disease
- high throughput
- chronic kidney disease
- newly diagnosed
- ejection fraction
- allergic rhinitis
- computed tomography
- binding protein
- oxidative stress
- prognostic factors
- pet ct
- risk assessment
- climate change
- working memory
- cell free
- positron emission tomography
- patient reported outcomes
- single cell
- cystic fibrosis
- dna binding
- biofilm formation
- staphylococcus aureus
- candida albicans
- atopic dermatitis